TGFB1 and hepatocellular carcinoma: In the AG1523 fibroblasts, as in HCC, the synthetic promoter was activated by TGFβ, whereas T0901317 co-administration exhibited a trend to diminish the promoter activation, which was not significant (Fig. 5g).